Clinical Trials Browser

Bone Marrow Diseases, Hematologic Diseases, Leukemia, Leukemia, Myeloid, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT02504372 2026-03-17

PEARLS

Phase 3 Completed

1,177 enrolled 21 charts 1 FDA

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT02553967 2026-03-17

REMASCO

Phase NA Completed

49 enrolled

Breast

Breast Neoplasms

NCT02818920 2026-03-17

TOP 1501

Phase 2 Completed

35 enrolled 11 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02947347 2026-03-17

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

Phase 3 Completed

445 enrolled 18 charts

Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT03070392 2026-03-17

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

Phase 2 Completed

378 enrolled 15 charts 1 FDA

Dermatologic

Uveal Melanoma, Melanoma

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Phase 1 Completed

15 enrolled 21 charts

Genitourinary

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT03292289 2026-03-17

QUALIPRO

Phase NA Completed

65 enrolled

Gastrointestinal

Rectal Neoplasms

NCT03462342 2026-03-17

CAPRI

Phase 2 Completed

123 enrolled

High Grade Serous Carcinoma

NCT04484142 2026-03-17

Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

Phase 2 Completed

137 enrolled 9 charts 1 FDA

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05120947 2026-03-17

HART-HN

Phase NA Completed

18 enrolled 11 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05393258 2026-03-17

Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas

Phase NA Completed

13 enrolled

CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT06056024 2026-03-17

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Phase 1 Completed

47 enrolled

Other solid neoplasm

Solid Tumor, KRAS Mutation

NCT00006721 2026-03-16

S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma

Phase 3 Completed

571 enrolled 12 charts

Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00417495 2026-03-16

IGASSU

Phase 2 Completed

216 enrolled

Breast

Adenocarcinoma, Breast Neoplasms

NCT00420563 2026-03-16

PAL-ANGI

Phase 2 Completed

88 enrolled

Tumor-Agnostic

Neoplasms

NCT01165333 2026-03-16

CILENT

Phase 1 Completed

32 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Glioma

NCT01303094 2026-03-16

T-DIS

Phase 2 Completed

53 enrolled

Sarcoma

NCT01658462 2026-03-16

VAROCE

Phase 2 Completed

51 enrolled

Breast

Breast Neoplasms

NCT01721343 2026-03-16

Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer

Phase NA Completed

516 enrolled

Neoplasms, Pain

NCT02437656 2026-03-16

METCAP

Phase 2 Completed

60 enrolled

Gastrointestinal

Rectal Neoplasms

NCT02439034 2026-03-16

KETOCOL

Phase 2 Completed

68 enrolled

GynecologicHead & Neck

Agnosia, Uterine Cervical Neoplasms, Head and Neck Neoplasms

Clinical Trials

PROTECT

SkinAge

ZUMA-2

Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers

KALICOU3

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

EREMISS

Study of DF1001 in Patients With Advanced Solid Tumors

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

MuciLight

A Study of DF6002 Alone and in Combination With Nivolumab

A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma

A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma

Asciminib Treatment Optimization in ≥ 3rd Line CML-CP

DRAIN-EXSU

A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

Exo-LCR

Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

App for Adverse Events to Oral Chemotherapy - Pilot Study

Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.

DOICA-E

Study of DF6215 in Patients With Advanced Solid Tumors

Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation

RAINBOW

COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT

MNEMOSYNE

Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

OPTIC

PEARLS

REMASCO

TOP 1501

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

QUALIPRO

CAPRI

Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

HART-HN

Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma

IGASSU

PAL-ANGI

CILENT

T-DIS

VAROCE

Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer

METCAP

KETOCOL